Eric Haltom is Senior Vice President, Clinical Operations at Deciphera Pharmaceuticals. Mr. Haltom joined Deciphera in 2016 and has over 30 years of experience in managing clinical operations gained from his work in both the academic setting, at the Dana Farber Cancer Institute, and industry setting, at the Genetics Institute, Biogen, and The Medicines Company. Over the past 16 years, he has successfully built and led clinical operations teams supporting Phase 1 to Phase 3 drug development programs and registries at both emerging biotechnology and established pharmaceutical companies including Shire and Acceleron Pharma. He has contributed to drug development programs intended to provide new therapeutic options to patients with cancer, cardiovascular, central nervous system (CNS) and rare disease indications. Mr. Haltom received a B.A. in Business from Saint Anselm College.